Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
Methods of Documentation VI: Case Management Model01:15

Methods of Documentation VI: Case Management Model

628
The case management model is a multidisciplinary approach that involves healthcare professionals from diverse disciplines, such as physicians, nurses, therapists, social workers, and pharmacists, working collaboratively to address the various needs of patients. Each healthcare professional brings unique expertise and perspectives, contributing to a more comprehensive understanding of the patient's condition and tailoring treatment plans accordingly.
For example, a patient with a chronic...
628
Issues And Trends In Healthcare Delivery System01:29

Issues And Trends In Healthcare Delivery System

5.8K
The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
5.8K
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

383
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
383
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

126
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
126
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

374
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
374

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correction: <i>Akkermansia muciniphila</i> regulates the gut microenvironment and alleviates periodontal inflammation in mice with periodontitis.

Frontiers in microbiology·2026
Same author

Determination and Ecological Risk Assessment of Organophosphate Esters in Drinking and Environmental Waters by Automated Liquid-Liquid Extraction Coupled with GC-MS/MS.

Molecules (Basel, Switzerland)·2026
Same author

WDBDM: Wavelet-based dual-branch diffusion model for low-dose CT and PET denoising.

Computerized medical imaging and graphics : the official journal of the Computerized Medical Imaging Society·2026
Same author

Integrated bioinformatics analysis and experimental validation reveal circFoxO1 as a regulator of pathological cardiac hypertrophy.

3 Biotech·2026
Same author

Online matrix elimination and high-sensitivity detection of maleic hydrazide in complex vegetable matrices using 2D-IC-IPAD.

Food chemistry·2026
Same author

Noise performance of InAs/GaSb/AlSb/GaSb SWIR FPA.

Optics express·2026
Same journal

Learning Moisture-Induced Damage From Vision: Diffusion Models for Real-Time Monitoring of Additive Manufacturing Processes.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same journal

Intrinsic Dual-Phase Regulated GeSe<sub>2</sub> Nanoparticles Triggered by Ball-Milling Treatment for Photonic Multi-Valued Logic Circuits.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same journal

A Plant Photoregulator-Inspired S-Type Heterojunction System for Diabetic Keratopathy via Tri-Modal Light-Driven Immunometabolic Reprogramming, Tissue Repair, and Antibacterial Activity.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same journal

eEF1G Orchestrates Translation to Ensure Meiotic Progression in Transcriptionally Quiescent Spermatocytes.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same journal

Ultrasound-Recharged Sub-Nanometer Palladium Catalysts for on-Demand and Self-Terminating Bioorthogonal Prodrug Activation in Cancer Therapy.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same journal

Graphene Aerogels With Spherical Pore Structure for Broad Frequency Regulation and Enhanced Low-Frequency Response.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
See all related articles

Related Experiment Video

Updated: Sep 11, 2025

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
07:13

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

4.5K

Personalized Medication for Chronic Diseases Using Multimodal Data-Driven Chain-of-Decisions.

Xiaoli Chu1, Yiheng Ye2, Siqiao Tang3

  • 1State Key Laboratory of Traditional Chinese Medicine Syndrome/Big Data Research Center of Chinese Medicine, The 2nd Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangdong, 510120, China.

Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|August 11, 2025
PubMed
Summary
This summary is machine-generated.

A new Multimodal Data-Driven Chain-of-Decisions (MDD-CoD) framework enhances personalized medication for chronic diseases. It integrates patient data with drug properties, improving treatment decisions and outcomes.

Keywords:
chain‐of‐decisionschronic diseasesmultimodal datapersonalized medications

More Related Videos

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
10:28

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Published on: July 24, 2019

15.4K
A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

7.6K

Related Experiment Videos

Last Updated: Sep 11, 2025

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
07:13

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

4.5K
Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
10:28

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Published on: July 24, 2019

15.4K
A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

7.6K

Area of Science:

  • Biomedical Informatics
  • Artificial Intelligence in Medicine
  • Pharmacogenomics

Background:

  • Personalized medication is crucial for chronic disease management but faces challenges integrating diverse patient and drug data.
  • Current models often rely on limited data types (clinical or molecular), hindering comprehensive patient-medication relationship modeling.
  • A sequential decision-making process is inherent in clinical practice for determining optimal medication regimens.

Purpose of the Study:

  • To propose a novel Multimodal Data-Driven Chain-of-Decisions (MDD-CoD) framework for personalized medication.
  • To integrate multimodal clinical phenotype data, multi-attribute medication data, and expert insights into a coherent decision-making process.
  • To improve the accuracy and interpretability of personalized medication recommendations for chronic diseases.

Main Methods:

  • Developed a three-stage deep learning framework (MDD-CoD) mimicking expert clinical decision-making.
  • Incorporated multimodal patient data (phenotypes) and medication attributes (macro- and micro-level).
  • Validated the framework on five datasets across four chronic diseases (CKD, MN, RA, CRC, KOA) from multiple hospitals.

Main Results:

  • The MDD-CoD framework demonstrated superior predictive performance in personalized medication decision-making compared to baseline models.
  • Achieved enhanced accuracy by integrating individual patient characteristics with comprehensive medication properties.
  • The model showed improved generalization and interpretability in cross-disease personalized decision-making tasks.

Conclusions:

  • The MDD-CoD framework offers a scalable and effective solution for personalized medication in chronic diseases.
  • This foundational model advances clinical decision support by leveraging multimodal data and a chain-of-decisions approach.
  • The framework holds promise for improving patient outcomes through more precise and individualized treatment strategies.